Inotiv Overview
- Year Founded
-
1974
- Status
-
Public
- Employees
-
2,055
- Stock Symbol
-
NOTV
- Investments
-
15
- Share Price
-
$1.93
- (As of Friday Closing)
Inotiv General Information
Description
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Contact Information
Website
www.inotiv.comCorporate Office
- 2701 Kent Avenue
- West Lafayette, IN 47906
- United States
Corporate Office
- 2701 Kent Avenue
- West Lafayette, IN 47906
- United States
Inotiv Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.93 | $1.97 | $1.23 - $11.42 | $50.1M | 26M | 183K | -$3.84 |
Inotiv Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 30-Sep-2023 | FY 2022 30-Sep-2022 | FY 2021 30-Sep-2021 |
|---|---|---|---|---|
| EV | 439,682 | 474,570 | 777,691 | 494,356 |
| Revenue | 501,062 | 572,425 | 547,656 | 89,605 |
| EBITDA | (10,981) | (26,506) | (273,421) | 14,070 |
| Net Income | (99,217) | (105,140) | (337,018) | 10,895 |
| Total Assets | 774,588 | 856,530 | 962,900 | 321,856 |
| Total Debt | 429,785 | 417,641 | 386,492 | 174,127 |
Inotiv Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Inotiv Comparisons
Industry
Financing
Details
Inotiv Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SGS | Corporation | Geneva, Switzerland | ||||
| TÜV SÜD | Corporation | Munich, Germany | ||||
| Element Materials Technology | Private Equity-Backed | London, United Kingdom | ||||
| ALS | Corporation | Everton Park, Australia | ||||
| FORCE Technology | Accelerator/Incubator Backed | Brondby, Denmark |
Inotiv Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Inotiv Patents
Inotiv Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2814539-A1 | Systems and methods for sample collection | Active | 11-Oct-2010 | ||
| ES-2594407-T3 | Systems and procedures for sample collection | Active | 11-Oct-2010 | ||
| US-20150093837-A1 | Devices, systems, and methods for the collection of body fluids | Active | 11-Oct-2010 | ||
| ES-2567412-T3 | Devices, systems and methods for collecting body fluids | Active | 11-Oct-2010 | ||
| US-9726583-B2 | Devices, systems, and methods for the collection of body fluids | Active | 11-Oct-2010 | G01N1/2813 |
Inotiv Executive Team (20)
| Name | Title | Board Seat |
|---|---|---|
| Robert Leasure | Chief Executive Officer, President and Director | |
| Beth Taylor | Chief Financial Officer & Senior Vice President of Finance | |
| John Beattie | Chief Operating Officer, Operations | |
| John Sagartz Ph.D | Board Member & Chief Strategy Officer, Strategy | |
| Scott Daniels | Senior Vice President of Drug Discovery and Translational Sciences |
Inotiv Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| Inotiv | Board Member & Chief Strategy Officer, Strategy | ||
| Self | Board Member | ||
| Self | Board Member | ||
| Self | Board Member | ||
| Inotiv | Chief Executive Officer, President and Director |
Inotiv Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Inotiv Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Inotiv Investments & Acquisitions (15)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Protypia | 30-Jul-2022 | Other Healthcare Technology Systems | |||
| Histion | 25-Apr-2022 | Laboratory Services (Healthcare) | |||
| Orient BioResource Center | 27-Jan-2022 | Other Healthcare Services | |||
| Integrated Laboratory Systems | 10-Jan-2022 | BPO/Outsource Services | |||
| Robinson Services (Rabbit Breeding and Supply Business) | 29-Dec-2021 | Merger/Acquisition | Animal Husbandry |
Inotiv Subsidiaries (3)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Protypia | Other Healthcare Technology Systems | Nashville, TN | 2017 |
| Pre-Clinical Research Services | Other Healthcare Services | Fort Collins, CO | |
| Envigo (Healthcare Services) | Other Healthcare Services | Indianapolis, IN |
Inotiv ESG
Risk Overview
Risk Rating
Updated February, 28, 2023
27.63 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,708
Rank
Percentile
Healthcare
Industry
of 626
Rank
Percentile
Medical Services
Subindustry
of 111
Rank
Percentile
Inotiv Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Algorithme Pharma USA | 01-Jan-2002 | Completed |
|
Inotiv FAQs
-
When was Inotiv founded?
Inotiv was founded in 1974.
-
Who is the CEO of Inotiv?
Robert Leasure is the CEO of Inotiv.
-
Where is Inotiv headquartered?
Inotiv is headquartered in West Lafayette, IN.
-
What is the size of Inotiv?
Inotiv has 2,055 total employees.
-
What industry is Inotiv in?
Inotiv’s primary industry is Other Commercial Services.
-
Is Inotiv a private or public company?
Inotiv is a Public company.
-
What is Inotiv’s stock symbol?
The ticker symbol for Inotiv is NOTV.
-
What is the current stock price of Inotiv?
As of 04-Oct-2024 the stock price of Inotiv is $1.93.
-
What is the current market cap of Inotiv?
The current market capitalization of Inotiv is $50.1M.
-
What is Inotiv’s current revenue?
The trailing twelve month revenue for Inotiv is $501M.
-
Who are Inotiv’s competitors?
SGS, TÜV SÜD, Element Materials Technology, ALS, and FORCE Technology are some of the 9 competitors of Inotiv.
-
What is Inotiv’s annual earnings per share (EPS)?
Inotiv’s EPS for 12 months was -$3.84.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
